ExoDx Prostate Evaluation in Active Surveillance Patient Population

Inclusion Criteria:

Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen

Exclusion Criteria:

Clinical symptoms of urinary tract infection at time of enrollment.
History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
Known hepatitis or HIV
History of concurrent renal/bladder tumors